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Abstract: The biocatalytic synthesis of xylooligosaccharides of daidzein was investigated 
using cultured cells of Catharanthus roseus and Aspergillus sp. β-xylosidase. The cultured 
cells  of  C.  roseus  converted  daidzein  into  its  4'-O-β-glucoside,  7-O-β-glucoside,  and  
7-O-β-primeveroside, which was a new compound. The 7-O-β-primeveroside of daidzein 
was  further  xylosylated  by  Aspergillus  sp.  β-xylosidase  to  daidzein  trisaccharide,  i.e.,  
7-O-[6-O-(4-O-(β-D-xylopyranosyl))-β-D-xylopyranosyl]-β-D-glucopyranoside, which was a 
new  compound.  The  4'-O-β-glucoside,  7-O-β-glucoside,  and  7-O-β-primeveroside  of 
daidzein exerted DPPH free-radical scavenging and superoxide radical scavenging activity. 
On the other hand, 7-O-β-glucoside and 7-O-β-primeveroside of daidzein showed inhibitory 
effects on IgE antibody production. 
Keywords:  daidzein;  xylooligosaccharide;  biocatalyst;  anti-oxidant  activity;  
anti-allergic activity 
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1. Introduction 
Daidzein  is  one  of  the  most  important  soy  isoflavonoids  and  has  been  recognized  as  a  natural 
antioxidant. It has been reported to show anti-allergic activities such as inhibitory effects on histamine 
release  from  mast  cells  [1–5].  However,  their  use  as  food-ingredients  is  limited  because  of  their  
water-insolubility and low absorbability after oral administration. 
Biocatalytic glycosylation using cultured cells and enzymes as biocatalysts is useful for preparing 
water-soluble  and  stable  glycosides  from  water-insoluble  and  unstable  organic  compounds  [6–11]. 
Furthermore, it has been reported that glycosylation of a lipophilic flavonoid, i.e., quercetin, improved 
its absorbability after oral administration [12]. From the viewpoint of pharmacological development of 
isoflavonoids,  their  glycosylation  is  of  importance.  We  report  here  the  synthesis  of  glycosides  of 
daidzein such as 7-O-β-primeveroside and 7-O-[6-O-(4-O-(β-D-xylopyranosyl))-β-D-xylopyranosyl]-
β-D-glucopyranoside,  which  were  two  new  compounds,  by  biocatalytic  glycosylation  of  daidzein  
with  cultured  cells  of  Catharanthus  roseus  and  Aspergillus  sp.  β-xylosidase.  We  also  report their  
anti-oxidant activities such as 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activity and 
superoxide-radical scavenging activity, and the inhibitory activity for IgE antibody formation. 
2. Results and Discussion 
2.1. Biocatalytic Glycosylation of Daidzein (1) by Cultured Cells of C. roseus and Aspergillus sp.  
β-Xylosidase 
HPLC analyses of the MeOH extracts of cultured cells of C. roseus revealed that neither daidzein 
nor its glycosides existed in the cell cultures. After incubation of cultured cells of C. roseus with 
daidzein (1) for five days, the products 2–4 were isolated from the cells by extraction with MeOH.  
No additional products were detected in the MeOH extracts of the cells despite careful HPLC analyses. 
On  the  basis  of  their  HRFABMS, 
1H  and 
13C  NMR  (Table  1),  H-H  COSY,  C-H  COSY,  and  
NOE-spectroscopic analyses, the products were determined to be daidzein 4'-O-β-glucoside (2, 2%), 
daidzein 7-O-β-glucoside (3, 30%), and daidzein 7-O-β-primeveroside (4, 5%) (Figure 1), of which  
4 is new. 
Table 1. 
13C chemical shifts of the glycosylation products 2–5 in DMSO-d6. 
Product  2  3  4  5 
2  153.0  153.1  153.1  153.1 
3  122.0  122.0  122.1  122.1 
4  174.6  174.6  174.6  174.6 
5  127.0  127.0  127.0  127.0 
6  115.5  115.5  115.4  115.4 
7  161.2  161.3  161.3  161.3 
8  103.3  103.3  103.3  103.3 
9  157.2  157.2  157.2  157.1 
10  118.4  118.4  118.4  118.4 Int. J. Mol. Sci. 2011, 12                       
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Table 1. Cont. 
Product  2  3  4  5 
1'  123.6  123.6  123.6  123.6 
2'  130.0  130.0  130.0  130.0 
3'  114.9  114.9  114.9  114.9 
4'  157.0  156.9  156.9  156.9 
5'  114.9  114.9  114.9  114.9 
6'  130.0  130.0  130.0  130.0 
1''  99.5  99.9  99.9  99.5 
2''  73.0  73.0  73.3  73.0 
3''  77.0  77.0  76.0  76.8 
4''  69.5  69.8  69.9  69.5 
5''  76.4  76.1  75.9  76.4 
6''  60.7  60.5  68.7  68.8 
1'''      103.5  103.5 
2'''      72.9  72.8 
3'''      76.5  76.1 
4'''      69.3  78.2 
5'''      60.9  61.0 
1''''        103.6 
2''''        72.9 
3''''        76.7 
4''''        68.9 
5''''        60.8 
Figure 1. Synthesis of β-xylooligosaccharides of daidzein (1) by C. roseus and Aspergillus 
β-xylosidase. 
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The molecular formula of 4 was established as C26H28O13 based on its HRFABMS spectrum, which 
included a pseudomolecular ion [M + Na]
+ peak at m/z 571.1205. HRFABMS suggested that 4 was 
composed of one of each of the following molecules of 1: hexose, and pentose. Its 
1H NMR spectrum 
showed two anomeric proton signals at δ 4.20 (1H, d, J = 8.0 Hz) and 5.10 (1H, d, J = 7.6 Hz). This 
suggested the presence of two β-anomers. The 
13C NMR spectrum  included two anomeric carbon 
signals at δ 99.9 and 103.5. The sugar components of 4 were determined to be β-D-glucopyranose and  
β-D-xylopyranose based on the chemical shifts of the carbon signals. The 
13C resonance of C-6'' was 
shifted downfield to δ 68.7. Correlations were observed between the anomeric proton signal at δ 5.10 
(H-1'') and the carbon signal at δ 161.3 (C-7), and between the anomeric proton signal at δ 4.20 (H-1''') 
and the carbon signal at δ 68.7 (C-6'') in the HMBC spectrum. These findings confirmed that the inner 
glucopyranosyl residue was attached to the phenolic hydroxyl group at C-7 of daidzein (1), and that  
the pair of β-D-glucopyranosyl residue and β-D-xylopyranosyl residue was 1,6-linked. Thus, 4 was 
identified as daidzein 7-O-[6-O-(β-D-xylopyranosyl)]-β-D-glucopyranoside (7-O-β-primeveroside). 
Enzymatic glycosylation of daidzein 7-O-β-primeveroside (4) using β-xylosidase from Aspergillus 
sp. as a biocatalyst afforded product 5 (Figure 1). The structure of product 5 was identified on the basis 
of HRFABMS, 
1H and 
13C NMR (Table 1), H-H COSY, C-H COSY, and HMBC-spectra as daidzein  
7-O-[6-O-(4-O-(β-D-xylopyranosyl))-β-D-xylopyranosyl]-β-D-glucopyranoside  (15%),  which  is  a  
new compound. 
Product 5 was assigned an Mr of 703.1902 [M + Na]
+ in the HRFABMS spectrum, which suggested  
a  molecular  formula  of  C31H36O17.  In  the 
13C  NMR  spectrum  of  5,  the  chemical  shifts  of  the  
sugar  carbon  signals  indicated  that  the  sugar  components  in  5  were  β-D-glucopyranose  and  
β-D-xylopyranose. Correlations were observed in the HMBC spectrum between the proton signal at  
δ 5.11 (H-1'') and the carbon signal at δ 161.3 (C-7), between the proton signal at δ 4.51 (H-1''')  
and  the  carbon  signal  at  δ  68.8  (C-6''),  and  between  the  proton  signal  at  δ  4.22  (H-1'''')  and  the  
carbon signal at δ 78.2 (C-4'''). These results confirmed that the  inner β-D-glucopyranosyl residue  
was  attached  to  the  phenolic  hydroxyl  group  at  C-7  of  daidzein,  that  second  β-D-xylopyranosyl  
residue  and  inner  β-D-glucopyranosyl  residue  were  1,6-linked,  and  that  the  third  and  second  
β-D-xylopyranosyl  residues  were  1,4-linked.  Thus,  compound  5  was  identified  as  daidzein  
7-O-[6-O-(4-O-(β-D-xylopyranosyl))-β-D-xylopyranosyl]-β-D-glucopyranoside. 
2.2. Anti-Oxidant Activity of Glycosides of Daidzein 
The DPPH free-radical scavenging activity of daidzein (1) and its β-glycosides 2–5 was examined 
by in vitro bioassay. The antioxidant activities were expressed as IC50 values summarized in Table 2. 
Daidzein  4'-O-β-D-glucoside  (2)  and  daidzein  7-O-β-D-glucoside  (3)  showed  strong  DPPH  
free-radical scavenging activity. As compared with the antioxidative property of daidzein, glucosylation 
of daidzein slightly decreased its antioxidant activity. Daidzein 7-O-β-primeveroside (4) had relatively 
low antioxidant activity. The results obtained  here suggested that glucosides and primeveroside  of 
daidzein would be potent free-radical scavenging antioxidants with aqueous-solubility. Int. J. Mol. Sci. 2011, 12                       
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Table 2. Antioxidant activities of daidzein β-glycosides 2–5. 
Compound 
  IC50 (μM) 
DPPH Free-Radical Scavenging  Superoxide-Radical Scavenging 
1  50  751 
2  70  802 
3  55  767 
4  121  870 
5  177  908 
Vitamin C  38  698 
 
The  superoxide-radical  scavenging  activity  of  daidzein  β-glycosides  2–5  was  expressed  as  IC50 
values and were summarized in Table 2. The activity of daidzein4'-O-β-D-glucoside (2) and daidzein  
7-O-β-D-glucoside (3) was strong and that of daidzein 7-O-β-primeveroside (4) was low. Daidzein  
7-O-[6-O-(4-O-(β-D-xylopyranosyl))-β-D-xylopyranosyl]-β-D-glucopyranoside  (5)  rarely  showed 
superoxide-radical  scavenging  activity.  The  results  obtained  here  suggested  that  glucosides  of  
daidzein would be potential superoxide-radical scavenging antioxidants. Studies on Trolox equivalent 
antioxidant capacity (TEAC) of the glycosides are now in progress. 
2.3. Anti-Allergic Activity of Glycosides of Daidzein 
The effects of daidzein (1) and its β-glycosides 2–5 on IgE antibody formation were examined by  
in vivo bioassay using 7S-globulin from soybean as an antigen. The average rat plasma IgE level after 
treatment of 7S-globulin with or without test compounds is summarized in Table 3. Daidzein showed 
the  highest  anti-allergic  activity  among  the  compounds  tested.  Daidzein7-O-β-D-glucoside  (3)  
and daidzein 7-O-β-primeveroside (4) showed inhibitory action on IgE antibody generation. On the 
other  hand,  daidzein  4'-O-β-glucoside  (2)  and  daidzein  7-O-[6-O-(4-O-(β-D-xylopyranosyl))-β-D-
xylopyranosyl]-β-D-glucopyranoside (5) did not inhibit the IgE antibody formation. 
Table 3. Suppressive action of daidzein β-glycosides 2–5 on IgE antibody formation. 
Compound  IgE Level 
a 
None  410.0 
1  141.7 
2  422.5 
3  158.0 
4  197.7 
5  339.8 
Hydrocortisone  338.0 
a  The  results  were  expressed  as  average  of plasma  IgE  level  of 7  rats administered  a  total  of  
10 mg/kg of each test compound. 
Recently,  it  has  been  reported  that  7-O-β-glycosides  of  genistein  showed  anti-allergic  activity,  
i.e., inhibitory action on histamine release from rat peritoneal mast cells, whereas the β-glycosides,  
the sugar of which attached at other phenolic hydroxyl groups, exhibited no anti-allergic actions [13]. 
The results of the present study suggested that β-glucoside and β-primeveroside at C-7 of daidzein did Int. J. Mol. Sci. 2011, 12                       
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not  attenuate  the  anti-allergic  activity,  and  that  phenolic  hydroxyl  groups  at  4'-position  might  be 
necessary  for  the  anti-allergic  action  of  glycosides  of  daidzein.  Studies  on  the  mechanism  of  
β-glycosides of daidzein to act as anti-allergic formulations are now in progress. 
2.4. Water-Solubility of Glycosides of Daidzein 
The water-solubility of daidzein (1) and its β-glycosides 2–5 was examined and summarized  in 
Table  4.  In  the  case  of  daidzein  7-O-[6-O-(4-O-(β-D-xylopyranosyl))-β-D-xylopyranosyl]-β-D-
glucopyranoside (5), conjugation of daidzein to three glycoside units enhanced the water-solubility to 
1.0 μmol/mL, which was 850 fold higher than that of 1 (1.2 × 10
−3 μmol/mL). 
Table 4. Water-solubility of daidzein (1) and its β-glycosides 2–5. 
Compound  Water-Solubility (μmol/mL)  Fold
 a 
1  1.2 × 10
−3  1 
2  3.5 × 10
−2  29 
3  4.0 × 10
−2  33 
4  0.2  183 
5  1.0  850 
a  Fold  of  water-solubility  of  glycosides  2–5  is  expressed  relative  to  that  of  their  aglycone  1, 
normalized to 1. 
3. Experimental Section 
3.1. General 
Daidzein was purchased from Sigma-Aldrich Co. Aspergillus sp. β-xylosidase was obtained from 
Dr.  Otsuka  of  Okayama  University  of  Science.  The  NMR  spectra  were  recorded  in  DMSO-d6  
using  a  Varian  XL-400  spectrometer.  The  chemical  shifts  were  expressed  in  δ  (ppm)  referring  to 
tetramethylsilane.  The  HRFABMS  spectra  were  measured  using  a  JEOL  MStation  JMS-700 
spectrometer. HPLC was carried out on a YMC-Pack R&D ODS column (150 × 30 mm) [solvent: 
CH3CN:H2O (3:17, v/v); detection: UV (280 nm); flow rate: 1.0 mL/min]. 
3.2. Cell Line and Culture Conditions 
The cultured plant cells of C. roseus have been cultivated over 20 years  in our laboratory and 
subcultured  in  300  mL  conical  flasks  containing  Schenk  and  Hildebrand  (SH)  medium  (100  mL,  
pH 5.7) on a rotary shaker (120 rpm) at 25 °C in the dark for every 3–5 weeks. Part of the callus 
tissues (fresh weight 30 g) was transplanted to freshly prepared SH medium (100 mL in a 500 mL 
conical flask, pH 5.7) containing 3% sucrose and was incubated for 3 weeks prior to use for this work. 
3.3. Glycosylation of Daidzein by C. roseus 
Daidzein (0.08 mmol) dissolved in EtOH 300 μL was individually administered to a 500-mL flask 
containing suspension cultured cells of C. roseus. The cultures were then incubated at 25 °C for five 
days on a rotary shaker (120 rpm) under illumination. After incubation, the cells and medium were Int. J. Mol. Sci. 2011, 12                       
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separated by filtration with suction. The filtered medium was extracted with EtOAc. The medium was 
further extracted with n-BuOH. EtOAc and n-BuOH fractions were analyzed by HPLC The cells were 
extracted with MeOH for 12 h and sonicated for 5 min. The yields of the glycosylation products were 
calculated  on  the  basis  of  the  peak  area  from  HPLC  using  calibration  curves  prepared  by  HPLC 
analyses of the authentic glycosides. The MeOH fraction was conc. and partitioned between H2O and 
EtOAc.  The  EtOAc  fractions  were  combined  and  analyzed  by  the  HPLC.  The  H2O  fraction  was 
applied to a Diaion HP-20 column and the column was washed with H2O followed by elution with 
MeOH. The MeOH eluate was subjected to HPLC to give glycosylated products. 
Spectral data of a new compound, daidzein 7-O-β-primeveroside (4): HRFABMS: m/z 571.1205  
[M + Na]
+; 
1H NMR (DMSO-d6): δ 3.15-3.70 (11H, m, H-2'', 2''', 3'', 3''', 4'', 4''', 5'', 5''', 6''), 4.20 (1H, d, 
J = 8.0 Hz, H-1'''), 5.10 (1H, d, J = 7.6 Hz, H-1''), 6.82 (2H, d, J = 6.4 Hz, H-3', 5') , 7.12 (1H, dd,  
J = 8.6, 2.0 Hz, H-6), 7.24 (1H, d, J = 1.9 Hz, H-8), 7.40 (2H, d, J = 6.4 Hz, H-2', 6'), 8.05 (1H, d,  
J = 8.6 Hz, H-5), 8.39 (1H, s, H-2); 
13C NMR (DMSO-d6): see Table 1. 
3.4. Glycosylation of Daidzein 7-O-β-Primeveroside by Aspergillus sp. β-Xylosidase 
The  transglycosylation  reaction  using  Aspergillus  sp.  β-xylosidase  was  carried  out  at  37  °C  in  
25 mM sodium phosphate buffer. To a solution containing 0.1 mmol of daidzein 7-O-β-primeveroside 
and  5  mmol  of  xylobiose  in  25  mM  of  HEPES-NaOH  buffer  (pH  7.5)  was  added  100  U  of  
β-xylosidase. After stirring of the reaction mixture for 24 h, the mixture was centrifuged at 3000 g for 
10 min. The supernatant was subjected on to a Sephadex G-25 column equilibrated with water to remove 
the enzyme. The fractions containing glycosides were purified by preparative HPLC to give a product. 
Spectral data of a new compound, daidzein 7-O-[6-O-(4-O-(β-D-xylopyranosyl))-β-D-xylopyranosyl]-
β-D-glucopyranoside (5): HRFABMS: m/z 703.1902 [M + Na]
+; 
1H NMR (DMSO-d6): δ 3.09–3.75 
(16H, m, H-2'',  2''',  2'''',  3'', 3''', 3'''',  4'',  4''', 4'''', 5'', 5''',  5'''', 6''), 4.22 (1H, d, J = 8.0 Hz, H-1''''),  
4.51 (1H, d, J = 8.0 Hz, H-1'''), 5.11 (1H, d, J = 7.6 Hz, H-1''), 6.82 (2H, d, J = 6.4 Hz, H-3', 5'),  
7.13 (1H, dd, J = 8.6, 2.0 Hz, H-6), 7.24 (1H, d, J = 2.0 Hz, H-8), 7.41 (2H, d, J = 6.4 Hz, H-2', 6'), 
8.04 (1H, d, J = 8.6 Hz, H-5), 8.39 (1H, s, H-2); 
13C NMR (DMSO-d6): see Table 1. 
3.5. DPPH Radical Scavenging Activity 
DPPH free-radical scavenging activities of β-glycosides of daidzein were determined as follows. 
DPPH was dissolved in ethanol (500 μM) [14].
 The sample solutions were prepared by dissolving each 
compound in ethanol. To a solution containing 0.1 mL of various concentration of each sample and  
0.9 mL of ethanol was added 1 mL of DPPH solution at room temperature. Vitamin C was used as a 
positive control. After 20 min at 25 °C, the absorbance was measured at 517 nm. The percentage 
reduction of the initial DPPH adsorption, i.e., the free-radical scavenging activity, was calculated as 
follows: E = [(Ac − At)/Ac] × 100, where At and Ac are the respective absorbance at 517 nm of sample 
solutions with and without the test compounds. Antioxidant activity was expressed as the 50% inhibitory 
concentration (IC50). Int. J. Mol. Sci. 2011, 12                       
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3.6. Superoxide-Radical Scavenging Activity 
Superoxide  was  generated  by  the  xanthine-xanthine  oxidase  system  [14].  The  reaction  mixture 
contained 50 μL of 4 mM xanthine, 50 μL of various concentration of sample in ethanol, 50 μL of  
2 mM nitro blue tetrazolium (NBT), 50 μL of 0.3 nkat/mL xanthine oxidase, and 0.1 M phosphate 
buffer (pH 7.4) in a total volume of 2 mL. Vitamin C was used as a positive control. The reaction 
mixture was incubated at 25 °C for 10 min and the absorbance was read at 560 nm. Percent inhibition 
was calculated by comparing with control without test compound but containing the same amount  
of alcohol. The IC50 value is shown as the sample concentration at which 50% of superoxide-radical 
was scavenged. 
3.7. Suppressive Action on IgE Antibody Formation 
The  inhibitory  action  of  β-glycosides  of  daidzein  on  IgE  antibody  formation  was  examined  as 
follows. 7S-Globulin was used as the antigen (1 mg/rat), and Al(OH)3 and pertussis vaccine were used 
as the adjuvants (20 mg and 0.6 mL/rat, respectively). Sensitization was made by injection of a mixture 
(0.6 mL) of the antigen and the adjuvant into the paws of each rat (male, ca. 200 g). Paw edema was 
measured  24  h  after  injection  and  the  treated  rats  were  divided  in  groups  with  an  equal  average 
swelling volume. Each sample was dissolved in physiological saline containing 10% Nikkol and the 
solution was injected daily into the rat for 11 d starting on the day of grouping. Hydrocortisone was 
used as the positive control. The amount of IgE was measured by the passive cutaneous anaphylaxis 
method on the 15th day [15]. The results were expressed as average of plasma IgE level of 7 rats 
administered a total of 10 mg/kg of each test compound. 
3.8. Water-Solubility 
Water-solubility  of  daidzein  and  its  β-glycosides  was  examined  as  follows.  Each  compound  
was stirred in water for 24 h at 25 °C. The mixture was centrifuged at 100,000 g for 30 min at 25 °C. 
The concentration of test compounds was estimated on the basis of their peak areas using calibration 
curves prepared by HPLC analyses of authentic samples. 
4. Conclusions 
The xylooligosaccharides of daidzein, that is, water-soluble daidzein derivatives, were synthesized 
by  sequential  biocatalytic  glycosylation  with  cultured  cells  of  C.  roseus  and  β-xylosidase  from 
Aspergillus  sp.  The  β-glucosides  and  β-primeveroside  of  daidzein  exerted  DPPH  free-radical 
scavenging and superoxide radical scavenging activity. The7-O-β-glucoside and 7-O-β-primeveroside of 
daidzein showed inhibitory effects on IgE antibody production. Further studies on the basic toxicological 
properties such as anticancer activity of the newly synthetic compounds are now in progress. 
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